Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
This article was originally published in The Rose Sheet
Executive Summary
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
You may also be interested in...
FDA Reorganization Elevates Scientific And Food Safety Priorities
The FDA Commissioner says the realignment of four deputy-level offices in the Office of the Commissioner will streamline "common activities" and strengthen science and food safety
FDA Reorganization Elevates Scientific And Food Safety Priorities
The FDA Commissioner says the realignment of four deputy-level offices in the Office of the Commissioner will streamline "common activities" and strengthen science and food safety
Tight 90-Day Countdown To Create Tobacco Center Poses Challenge For FDA
FDA has its work cut out for it to establish a Center for Tobacco Products within 90 days once President Obama adds his promised signature to the bill giving the agency regulatory authority over tobacco